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ABSTRACT
KEGG (http://www.genome.jp/kegg/) is a database
of biological systems that integrates genomic,
chemical and systemic functional information.
KEGG provides a reference knowledge base for
linking genomes to life through the process of
PATHWAY mapping, which is to map, for example,
a genomic or transcriptomic content of genes
to KEGG reference pathways to infer systemic
behaviors of the cell or the organism. In addition,
KEGG provides a reference knowledge base for
linking genomes to the environment, such as for
the analysis of drug-target relationships, through
the process of BRITE mapping. KEGG BRITE
is an ontology database representing functional
hierarchies of various biological objects, including
molecules, cells, organisms, diseases and drugs, as
well as relationships among them. KEGG PATHWAY
is now supplemented with a new global map of
metabolic pathways, which is essentially a combi-
ned map of about 120 existing pathway maps. In
addition, smaller pathway modules are defined and
stored in KEGG MODULE that also contains other
functional units and complexes. The KEGG resource
is being expanded to suit the needs for practical
applications. KEGG DRUG contains all approved
drugs in the US and Japan, and KEGG DISEASE is a
new database linking disease genes, pathways,
drugs and diagnostic markers.
INTRODUCTION
Since the completion of the Human Genome Project,
high-throughput experimental projects have been
initiated for uncovering genomic information in an
extended sense, including transcriptome and proteome,
as well as metabolome, glycome and other genome-
encoded information. Together with traditional genome
sequencing for an increasing number of organisms, we
are beginning to understand the genomic space of possible
genes and proteins that make up the biological system.
In contrast, we have very limited knowledge about the
chemical space of possible chemical substances that
exists as an interface between the biological world and
the natural world. This situation is rapidly changing
thanks to the chemical genomics initiatives for systematic
screening of biologically active chemical compounds and
the metagenomics initiatives giving insights into the
chemical environment that interacts with and drives
evolution of the biological system.
The KEGG project was initiated in 1995, coincidentally
when the ﬁrst genome of a free-living organism was
completely sequenced (1). KEGG PATHWAY has since
been utilized as a reference knowledge base for under-
standing higher-level functions of cellular processes and
organism behaviors from large-scale molecular data
sets. The addition of KEGG BRITE, a collection of
functional hierarchies with structured vocabularies,
signiﬁcantly increased our ability to represent and
utilize higher-level functional information, especially to
integrate genomic and chemical (environmental) informa-
tion (2). Here we report another new development
in KEGG, the integration of research results and
practical values in medical, pharmaceutical and
environmental sciences.
THE KEGG RESOURCE
Overview
As of January 2008, KEGG comprises 19 databases, cate-
gorized into systems information, genomic information
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databases in the chemical information category are
collectively called KEGG LIGAND. The six databases
in the lower part of the genomic information category are
computationally generated, but all the other 13 databases
are manually curated.
The KEGG databases are highly integrated. In fact,
KEGG should be viewed as a computer representation
of the biological system, where biological objects and
their relationships at the molecular, cellular and organism
levels are computerized as separate database entries. Each
database entry, called a KEGG object, is given a unique
identiﬁer within KEGG. Table 2 summarizes the naming
convention of such KEGG object identiﬁers for the
13 core databases. Except for GENES and ENZYME
that utilize the standard names of locus_tag and EC
number, and for GENOME that distinguishes organisms
with 3–4 letter KEGG organism codes, the KEGG object
identiﬁer is a ﬁve-digit number preﬁxed by an upper-case
alphabet or a 2–4 letter code (map, br or organism code).
Examples are: C00047 for lysine, K04527 for insulin
receptor and hsa05210 for colorectal cancer pathway.
These identiﬁers may be used to directly obtain
corresponding database entries with the ‘Get Entry’
option in the KEGG website (http://www.genome.jp/
kegg/). Interestingly, these identiﬁers may also be used
in web search engines, such as Google and Yahoo, to
obtain corresponding KEGG database entries. There are
already many databases that are linked to/from KEGG.
Such outside links will continue to be added to better
integrate KEGG with various other web resources.
Genomeannotation
Genome annotation in KEGG assigns KO (KEGG
Orthology) identiﬁers or K numbers to genes in a single
genome or simultaneously to genes in multiple genomes.
With the addition or revision of a KEGG pathway map
or BRITE hierarchy, KO groups (K numbers) are deﬁned
for the pathway nodes (boxes) or the hierarchy nodes
(bottom leaves). Then the corresponding genes in selected
organisms (usually in the literature) are manually anno-
tated with the new K numbers, which are reﬂected in
KEGG GENES. Thus, KEGG GENES can be used as a
reference database for genome annotation. The number of
KO groups has been increasing at a rate of about 2000 per
year, and it is now over 10000.
The KO assignment is applied to a new genome as
follows. First, the new genome is subject to SSDB
computation, a comparison of protein coding genes
against all existing genomes by the SSEARCH program.
The result is stored in KEGG SSDB containing sequence
similarity scores and best-hit information for all gene
pairs. Then, computational KO assignment is done by the
KAAS-SSDB program, followed by manual veriﬁcation
and additional assignment with the GFIT tool. An auto-
mated version of this genome annotation procedure is
made available as the KAAS web service (3), which
utilizes BLAST rather than SSEARCH for pairwise
genome comparisons.
The KO system is the basis for linking genomes to
biological systems through the process of pathway
mapping and BRITE mapping. For each organism in
KEGG, organism-speciﬁc pathways and BRITE hierar-
chies are computationally generated based on its assigned
K numbers. Microarray gene expression proﬁle data may
then be mapped to these pathways and hierarchies to infer
systemic functions of the cell or the organism. In addition
to the hierarchies of genes and proteins (K numbers),
KEGG BRITE contains the hierarchies of chemical
substances (C, D, G, R numbers) together with known
Table 1. KEGG databases
Category Database Content
Systems KEGG PATHWAY Pathway maps
information KEGG BRITE Functional hierarchies
KEGG MODULE Pathway modules
(released January 2008)
KEGG DISEASE Diseases (released
January 2008)
Genomic
information
KEGG ORTHOLOGY KEGG orthology
(KO) groups
KEGG GENOME KEGG organisms
KEGG GENES Genes in high-quality
genomes
KEGG DGENES Genes in draft genomes
KEGG EGENES Genes as EST contigs
KEGG VGENOME Viral genomes (to be fully
integrated)
KEGG VGENES Genes in viral genomes
(to be fully integrated)
KEGG OGENES Genes in organelle
genomes (to be fully
integrated)
KEGG SSDB Sequence similarities and
best hit relations
Chemical
information
KEGG COMPOUND Metabolites and other
chemical compounds
KEGG DRUG Drugs
KEGG GLYCAN Glycans
KEGG ENZYME Enzymes
KEGG REACTION Enzymatic reactions
KEGG RPAIR Reactant pairs and chemical
transformations
Table 2. KEGG object identiﬁers
Release Database Object identiﬁer
1995 KEGG PATHWAY map number
KEGG GENOME organism code (T number)
KEGG GENES locus_tag/NCBI GeneID
KEGG ENZYME EC number
KEGG COMPOUND C number
2001 KEGG REACTION R number
2002 KEGG ORTHOLOGY K number
2003 KEGG GLYCAN G number
2004 KEGG RPAIR A number
2005 KEGG BRITE br number
KEGG DRUG D number
2008 KEGG MODULE M number
KEGG DISEASE H number
See http://www.genome.jp/kegg/kegg3.html for details.
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interactions and drug–target relationships. By using
these relationships, the BRITE mapping will be improved
to present clues for understanding the interactions with
the environments.
Chemical annotation
The KO system can also be used for chemical annotation,
which is the linking of genomic or transcriptomic contents
of genes to chemical structures of endogenous molecules.
This is achieved by ﬁner classiﬁcations of KO groups
for speciﬁc classes of enzymes distinguishing diﬀerent
substrate speciﬁcity, as well as accumulating knowledge
of biosynthetic pathways. For example, glycans are
synthesized by a series of reactions catalyzed by glycosyl-
transferases. With the KEGG pathway maps for glycan
structures (map01030 and map01031) or the KEGG
GLYCAN composite structure map (4), where edges
(glycosidic linkages) correspond to K numbers (glycosyl-
transferase orthologs), the gene content in the genome
can be converted to possible glycan structures. In a similar
but more sophisticated way, glycan structures can
be predicted from microarray gene expression data (5).
The KEGG resource will be made suitable to cope with
the diversity of other molecules as well, including
polyketides/non-ribosomal peptides (6), polyunsaturated
fatty acids and terpenoids.
Another type of chemical annotation is to characterize
biological meaning in the chemical structures of small
molecules. As reported previously (2), the knowledge of
enzymatic reactions and associated chemical structure
transformations is stored in KEGG REACTION and
KEGG RPAIR. Each structure transformation is char-
acterized by the RDM pattern (7), and most of the
patterns are found uniquely or preferentially in speciﬁc
categories of KEGG pathways (8). This tendency was
used to predict the metabolic fate of xenobiotic chemical
compounds. Software for reaction/pathway prediction is
being developed as an upgrade of e-zyme and PathComp
in KEGG LIGAND.
Enhancements toKEGG pathway
KEGG PATHWAY has been signiﬁcantly expanded over
the last 2 years with the addition of about 50 new pathway
maps, mostly for signal transduction, cellular processes
and human diseases. However, the traditional KEGG
metabolic pathway maps are still most widely used
including the KGML (KEGG XML) version. They are
now supplemented with two new features introduced as a
response to user feedback. The ﬁrst feature is a global map
shown in Figure 1, which is created as an SVG ﬁle by
manually combining about 120 existing maps. Each node
(circle) is a chemical compound and each line (curved
or straight) connecting two nodes is a series of reactions
(one to several reactions), which is also manually deﬁned
as a segment lacking branches. The new KEGG metabo-
lism map allows the user to view and compare the entire
metabolism, such as by mapping metagenomics data
or microarray data. KGML users should also ﬁnd the
new KEGG metabolism map much easier to manipulate.
The other feature is KEGG MODULE, a new database
that collects pathway modules and other functional units
as a set of K numbers. Pathway modules are smaller pieces
of subpathways (see the BRITE hierarchy ko00002),
manually deﬁned as consecutive reaction steps, operon
or other regulatory units, phylogenetic units obtained by
genome comparisons, etc. This new database also contains
molecular complexes, facilitating better organization of
data and knowledge, especially in KEGG BRITE. The
hierarchy of molecular organization, such as the subunit
organization of transporters or receptors, is represented
by the M number that corresponds to a set of K numbers.
Incidentally, a line segment in the new KEGG metabolism
map that also corresponds to a set of K numbers is
identiﬁed by the N number, representing a mechanistically
deﬁned network segment.
KEGG formedical and pharmaceutical applications
As of September 2007, KEGG PATHWAY contains 26
maps for human diseases, among which 19 were intro-
duced in the last 2 years. The disease pathway maps are
classed in four subcategories: 6 as neurodegenerative
disorders (9), 3 as each of infectious diseases and
metabolic disorders and 14 as cancers. Although such
maps will continue to be added, they will never be
suﬃcient to represent our knowledge of molecular
mechanisms of diseases because in many cases it is too
fragmentary to represent as pathways. KEGG DISEASE
is another addition to the KEGG suite of databases
accumulating molecular-level knowledge on diseases
including genes, drugs and biomarkers. Our current
eﬀort is focused on the four subcategories of diseases
mentioned above.
The number of entries in KEGG DRUG has also
signiﬁcantly increased over the last 2 years, and now
covers all approved drugs in the US and Japan. KEGG
DRUG is a structure-based database. Each entry is a
unique chemical structure that is linked to standard
generic names, and is associated with eﬃcacy and target
information as well as drug classiﬁcations. Target
information is presented in the context of KEGG path-
ways and drug classiﬁcations are part of KEGG BRITE.
The generic names are linked to trade names and
subsequently to outside resources of package insert
information (patient information) whenever available.
This reﬂects our eﬀort to make KEGG more useful to
the general public.
ACCESSING KEGG
Via GenomeNet
KEGG is made available as the major component of the
Japanese GenomeNet service, operated by the Kyoto
University Bioinformatics Center. The top pages of the
KEGG website (http://www.genome.jp/kegg/) have been
changed for easier access to KGML, KEGG API and
KEGG FTP.
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Figure 1. The new KEGG metabolism map created as an SVG ﬁle.
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Because the KEGG system has become so large and
complex, the entire package is being redesigned and is
presented at a new site (http://www.kegg.jp/) that
currently contains a Japanese version only.
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